Ruwaidah Majeed

Ruwaidah Majeed practices at Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health.

Ruwaidah Majeed's NPI, 1851895262, was assigned on March 20, 2018. Ruwaidah Majeed holds New Jersey license 25MA11167600.

Ruwaidah Majeed's primary practice is Ocean University Medical Center, at 425 Jack Martin Blvd, Brick, NJ 08724 in Ocean County. The practice phone is (732) 840-2200.

Ruwaidah Majeed's primary practice is Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health. Ruwaidah Majeed is also affiliated with Jersey Shore University Medical Center. The medical group on file is Plover Inpatient Services LLC. Dmand AI also links Ruwaidah Majeed to 1 more hospital, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ruwaidah Majeed practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ruwaidah Majeed's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ruwaidah Majeed is licensed in New Jersey.

CMS data shows 1,522 Medicare services from Ruwaidah Majeed across 4 procedure codes in 2024, for 532 Medicare patients. Medicare paid $138,306 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 532 Medicare patients who saw Ruwaidah Majeed in 2024. The largest group is 75 to 84, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ruwaidah Majeed's median patient age at 77, with 52% women.

In 2024, Ruwaidah Majeed wrote 557 Medicare Part D claims for 180 patients. 87% of them were for generic drugs. CMS names the drug for 229 of them, across 12 drugs with 11 or more claims each, at $12,232 in total drug cost. In 2023, CMS named 138 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 26 out of 100 for Ruwaidah Majeed for performance year 2024, reported individually. Ruwaidah Majeed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Ruwaidah Majeed from 11 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Davol Inc. paid the most, $150.